Sonic Healthcare Ltd
ASX:SHL

Watchlist Manager
Sonic Healthcare Ltd Logo
Sonic Healthcare Ltd
ASX:SHL
Watchlist
Price: 22.985 AUD 0.04%
Market Cap: 11.4B AUD

Intrinsic Value

The intrinsic value of one SHL stock under the Base Case scenario is 35.943 AUD. Compared to the current market price of 22.985 AUD, Sonic Healthcare Ltd is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SHL Intrinsic Value
35.943 AUD
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sonic Healthcare Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about SHL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SHL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sonic Healthcare Ltd.

Explain Valuation
Compare SHL to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

A potential decline in Medicare and insurance reimbursement rates in key markets, especially the United States and Australia, could significantly reduce the profitability of Sonic’s large-scale laboratory operations and hamper the company’s ability to invest in new diagnostic technologies.

Ongoing consolidation among healthcare payers in Europe may pressure Sonic’s negotiated prices and volumes for pathology testing, challenging the company’s margin stability and limiting its ability to passing through cost increases.

Heavy investments in acquisitions have expanded Sonic’s global footprint, but integration challenges across diverse regulatory frameworks and IT infrastructure could lead to inefficiencies, increased costs, and operational disruptions.

Bull Theses

Sonic’s international scale and reputation for high-quality diagnostic services provide a competitive edge in securing large testing contracts with hospitals, which can drive stable revenue growth and margin expansion.

The company’s strategic expansion into new service lines, such as advanced genetics and specialty pathology, positions it to benefit from the growing demand for personalized medicine and comprehensive diagnostic solutions.

A strong balance sheet and robust cash flow generation enable Sonic to pursue additional acquisitions in fragmented markets, reinforcing its leading position and creating further opportunities for cost-benefit synergies.

Show More Less
How do you feel about SHL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sonic Healthcare Ltd

Current Assets 2.6B
Cash & Short-Term Investments 673.8m
Receivables 1.5B
Other Current Assets 388.2m
Non-Current Assets 13.4B
Long-Term Investments 231.1m
PP&E 3.3B
Intangibles 9.8B
Other Non-Current Assets 117.6m
Current Liabilities 2.2B
Accounts Payable 1.3B
Other Current Liabilities 909.4m
Non-Current Liabilities 5.5B
Long-Term Debt 4.7B
Other Non-Current Liabilities 797.1m
Efficiency

Free Cash Flow Analysis
Sonic Healthcare Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sonic Healthcare Ltd

Revenue
9.6B AUD
Cost of Revenue
-1.6B AUD
Gross Profit
8.1B AUD
Operating Expenses
-7.2B AUD
Operating Income
931.4m AUD
Other Expenses
-417.8m AUD
Net Income
513.6m AUD
Fundamental Scores

SHL Profitability Score
Profitability Due Diligence

Sonic Healthcare Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Gross Margin is Increasing
48/100
Profitability
Score

Sonic Healthcare Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

SHL Solvency Score
Solvency Due Diligence

Sonic Healthcare Ltd's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
38/100
Solvency
Score

Sonic Healthcare Ltd's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SHL Price Targets Summary
Sonic Healthcare Ltd

Wall Street analysts forecast SHL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHL is 27.816 AUD with a low forecast of 23.735 AUD and a high forecast of 34.965 AUD.

Lowest
Price Target
23.735 AUD
3% Upside
Average
Price Target
27.816 AUD
21% Upside
Highest
Price Target
34.965 AUD
52% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SHL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one SHL stock?

The intrinsic value of one SHL stock under the Base Case scenario is 35.943 AUD.

Is SHL stock undervalued or overvalued?

Compared to the current market price of 22.985 AUD, Sonic Healthcare Ltd is Undervalued by 36%.

Back to Top